Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Technologies: New Clinical Study, Research Collaboration Agreement With Lung Cancer Initiative At Johnson & Johnson

Sept 20 (Reuters) - Mauna Kea Technologies SAS  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES ANNOUNCES NEW CLINICAL STUDY AND
RESEARCH
COLLABORATION AGREEMENT WITH THE LUNG CANCER INITIATIVE AT
JOHNSON & JOHNSON
    * MAUNA KEA TECHNOLOGIES WILL PARTICIPATE IN A PROSPECTIVE,
MULTI-CENTER, OPEN-LABEL, SINGLE-ARM CLINICAL FEASIBILITY STUDY
LED BY LCI
    * STUDY WILL COMBINE NCLE AND ROBOTIC-ASSISTED BRONCHOSCOPY,
USING
BOTH CELLVIZIO AND MONARCH PLATFORM FROM AURIS HEALTH, INC.
    * LCI WILL SPONSOR AND FUND STUDY
    * LCI WILL PROVIDE TOTAL FUNDING TO COMPANY OF 978,375
EUROS, A
PORTION OF WHICH IS CONTINGENT UPON SUCCESSFUL COMPLETION OF
CERTAIN STUDY ACTIVITIES
    * LCI WILL PROVIDE TOTAL FUNDING TO COMPANY OF 978,375 EUROS

Source text for Eikon:  ID:nBw71zdSqa 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Mauna Kea Technologies SA

See all news